Home
/

What is a Triglycerides Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

A triglycerides blood test measures triacylglycerol—the body's primary fat storage molecule—circulating in lipoproteins, reflecting how efficiently your body handles dietary fat and liver-produced fuel. Desirable levels are below 150 mg/dL; levels of 200–499 mg/dL are considered high, while ≥500 mg/dL poses pancreatitis risk. Tracking triglycerides with a lipid panel may help support early identification of insulin resistance.

Read more →
Table of contents

Triglycerides: The Body's Main Energy-Carrying Fats

Triglycerides blood testing measures the amount of triglycerides—the body’s main storage form of fat—in your bloodstream. A triglyceride is a small energy package built from one glycerol backbone and three fatty acids (triacylglycerol). Triglycerides come from two places: they’re absorbed from food by the intestine and they’re made by the liver, especially from excess sugars. In the blood, they travel inside fat-carrying particles (lipoproteins): chylomicrons after a meal, and very-low-density lipoproteins (VLDL) from the liver.

This biomarker captures how your body stores and moves fuel. Triglycerides deliver fatty acids to muscles and the heart for energy and to fat tissue for storage, a process governed by enzymes that unload them from lipoproteins (lipoprotein lipase). The measured level reflects the balance between input from the gut and liver and clearance by tissues—essentially, how efficiently you handle and traffic energy from fats and sugars (lipid and carbohydrate metabolism).

Why Triglycerides Sit at the Crossroads of Metabolism

Triglycerides are the bloodstream’s main energy-carrying fats, packaged in particles from the gut and liver. They reflect how your intestine absorbs fat, how your liver handles surplus fuel, and how hormones like insulin direct energy between fat, muscle, and pancreas. Because they sit at the crossroads of metabolism, they signal risk across the heart, liver, and endocrine systems.

Big picture: triglycerides integrate gut, liver, adipose, and pancreatic signaling. Persistently high levels track with atherosclerotic risk, fatty liver, and future diabetes, while very high levels raise pancreatitis risk.

How a Triglyceride Value Reads From Optimal to Severe

Typical reference points: under 150 is desirable, 150–199 borderline, 200–499 high, and 500 or higher very high. For most people, within reference ranges sits toward the lower end of normal—not extremely low.

When values are unusually low, they often mirror limited fat intake or absorption, an overactive thyroid, chronic illness, or rare genetic patterns. The physiology is less fuel in circulation and fewer triglyceride-rich particles, which can coincide with poor delivery of fat-soluble vitamins; people may notice dry skin, night-vision changes, easy bruising, or muscle weakness if malabsorption is present. In children, very low levels can suggest undernutrition. During pregnancy, triglycerides normally rise, so low values are uncommon.

When values are elevated, the liver is typically overproducing VLDL under insulin resistance, or particles are not cleared well. This promotes remnant cholesterol, small dense LDL, low HDL, and fat buildup in the liver. Most people feel nothing; very high levels can cause abdominal pain from pancreatitis, eruptive skin bumps, and milky blood. Men with visceral fat and women after menopause often see higher levels; pregnancy drives a late-gestation rise, and genetic disorders may present in childhood.

What Distorts a Triglyceride Measurement

Notes: Interpretation depends on fasting versus nonfasting sampling, recent meals or alcohol, acute illness, and pregnancy timing. Age and sex shift typical values, with men and postmenopausal women tending higher. Assay and day‑to‑day biologic variability exist; reference intervals may differ across labs.

What a Triglyceride Result Adds to Cardiometabolic Risk

A triglycerides blood test measures the amount of triglyceride-rich lipoproteins (mainly VLDL and chylomicrons) in blood. Triglycerides carry energy from liver and gut to tissues. Levels reflect how you process sugars and fats and relate to cardiometabolic risk, fatty liver, and, at extremes, pancreatitis. They influence vessel health and energy delivery to muscle and brain.

Low values usually reflect reduced production or faster clearance of these particles. Causes include low energy intake or malabsorption, overactive thyroid (hyperthyroidism), chronic illness, and rare genetic ApoB disorders. System-wise this can signal limited circulating fuel and, in genetic forms, impaired transport of fat‑soluble vitamins. Pregnancy usually raises levels.

Being in range suggests balanced hepatic output and peripheral use of triglycerides, good insulin sensitivity, and vascular stability. Within the usual reference range, lower values are generally associated with lower cardiometabolic risk, especially on fasting measurements.

High values usually reflect excess liver export of VLDL or reduced tissue breakdown. Common drivers include insulin resistance or diabetes, too little thyroid hormone (hypothyroidism), kidney disease, alcohol, and drugs such as estrogens, steroids, some beta‑blockers, and retinoids. Genetic conditions and late pregnancy raise levels. System effects include atherogenic dyslipidemia, fatty liver, and pancreatitis risk when very high.

FAQs

Triglycerides testing measures the concentration of triglycerides in your blood to assess cardiometabolic and liver-related risk.

Testing helps identify atherosclerotic cardiovascular risk, pancreatitis risk at very high levels, insulin-resistant patterns, fatty liver risk, and secondary causes influenced by diet, alcohol, thyroid, kidney function, or medications.

Regular testing helps track response to lifestyle changes and therapies. Frequency depends on personal goals and risk factors; many people retest periodically to monitor trends.

Diet high in added sugars and refined starches, alcohol, weight gain, inactivity, insulin resistance, hypothyroidism, chronic kidney disease, and certain medications can raise levels. Increased activity, fiber, unsaturated fats, and omega-3s can lower them.

Fasting can improve comparability across tests, especially if you are monitoring change. Non-fasting measurements still provide meaningful risk information; follow the instructions provided with your test.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Feingold, K. R. (2024). Introduction to lipids and lipoproteins. In Endotext. MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK305896/
  2. Nordestgaard, B. G. (2016). Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: New insights from epidemiology, genetics, and biology. Circulation Research, 118(4), 547-563. https://doi.org/10.1161/CIRCRESAHA.115.306249
  3. Nordestgaard, B. G., Langsted, A., Mora, S., Kolovou, G., Baum, H., Bruckert, E., Watts, G. F., Sypniewska, G., Wiklund, O., Borén, J., Chapman, M. J., Cobbaert, C., Descamps, O. S., von Eckardstein, A., Kamstrup, P. R., Pulkki, K., Kronenberg, F., Remaley, A. T., Rifai, N., ... Langlois, M. (2016). Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points—A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. European Heart Journal, 37(25), 1944-1958. https://doi.org/10.1093/eurheartj/ehw152
  4. Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., ... Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation, 139(25), e1082-e1143. https://doi.org/10.1161/CIR.0000000000000625
  5. Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R., ... Wiklund, O. (2020). 2019 ESC/EAS guidelines for the management of dyslipidaemias. European Heart Journal, 41(1), 111-188. https://doi.org/10.1093/eurheartj/ehz455

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey